Should You Worry That Encompass Health's CEO Sold Into a Rally? Here's What to Know
The executives sold after Encompass Health raised guidance and said revenue grew 10%, with the CEO trimming about 39% of his direct stake.
2 Articles
2 Articles
What Three Encompass Health Insiders Selling Signals After a Rate Increase
Key PointsThe transaction realized approximately $1.1 million at a weighted average price of $125.95 per share.The executive reduced his direct common stock holdings by 11% through this open-market sale.Darby maintains a direct position of 75,041 shares following the transaction.10 stocks we like better than Encompass Health › John Patrick Darby, EVP and general counsel of Encompass Health Corporation (NYSE:EHC), sold 8,906 shares of common stoc…
Should You Worry That Encompass Health's CEO Sold Into a Rally? Here's What to Know
Encompass Health Corporation (NYSE:EHC) President and CEO Mark J. Tarr reported a sale of about 173,000 shares of common stock on August 10, according to a recent SEC Form 4 filing. Transaction summary Transaction value based on SEC Form 4 weighted average sale price ($125.47); post-transaction…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
